Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes

Daisuke Hasegawa, Osamu Nishida

研究成果: Letter › 査読

3 被引用数 (Scopus)

本文言語	English
ページ（範囲）	231
ページ数	1
ジャーナル	Critical care (London, England)
巻	23
号	1
DOI	https://doi.org/10.1186/s13054-019-2521-7
出版ステータス	Published - 24-06-2019

All Science Journal Classification (ASJC) codes

@article{ee88c4d097a345d7857499e9b75e5bfd,

title = "Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes",

author = "Daisuke Hasegawa and Osamu Nishida",

year = "2019",

month = jun,

day = "24",

doi = "10.1186/s13054-019-2521-7",

language = "English",

volume = "23",

pages = "231",

journal = "Critical Care",

issn = "1364-8535",

publisher = "Springer Science + Business Media",

number = "1",

}

TY - JOUR

T1 - Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes

AU - Hasegawa, Daisuke

AU - Nishida, Osamu

PY - 2019/6/24

Y1 - 2019/6/24

UR - http://www.scopus.com/inward/record.url?scp=85068745150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068745150&partnerID=8YFLogxK

U2 - 10.1186/s13054-019-2521-7

DO - 10.1186/s13054-019-2521-7

M3 - Letter

C2 - 31234901

AN - SCOPUS:85068745150

VL - 23

SP - 231

JO - Critical Care

JF - Critical Care

SN - 1364-8535

IS - 1

ER -